Kinarus Therapeutics 宣布与 Curatis AG 进行业务合并和反向股票分割。 Kinarus Therapeutics announces business combination with Curatis AG and reverse share split.

Kinarus Therapeutics Holding AG 发布其2023财年财务报表，宣布其与Curatis AG的业务合并和反向股票分割的细节。 Kinarus Therapeutics Holding AG releases its FY2023 financial statements, announcing the details of its business combination with Curatis AG and a reverse share split. 该公司还推迟发布2023年年度报告。 The company also postpones the publication of its Annual Report 2023. 与 Curatis AG 的业务合并和反向股票分割细节以及最终完成的时间表已经公布。 The business combination with Curatis AG and reverse share split details, along with the final timeline for their completion, have been announced.